Yüklüyor......
Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?
The Oncotype DX recurrence score (RS) reduces breast cancer adjuvant treatment utilization, but the reasons for this effect are not straightforward. We performed a retrospective chart review of 89 consecutive node-negative breast cancer patients for whom RS was ordered to facilitate adjuvant treatme...
Kaydedildi:
| Yayımlandı: | Breast Cancer Res Treat |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4349488/ https://ncbi.nlm.nih.gov/pubmed/22723033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-012-2134-1 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|